Home > PS Ratio > GLAND PHARMA

GLAND PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of GLAND PHARMA is 5.84.

Share Price ₹2,275.3Jun 02,2026
Market Cap ₹37,541.6 Cr
Sales-TTM₹6,430.7 CrTTM-Consolidated Results
Price/Sales5.84xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of GLAND PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of GLAND PHARMA is calculated as :

Current Market Cap [ ₹37,541.6 Cr] as on Jun 02,2026

(/) Sales [ ₹6,430.7 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 5.84x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for GLAND PHARMA , the investors are currently willing to pay '5.84 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of GLAND PHARMA !

The chart below summarizes the trend in P/S Ratio of GLAND PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of GLAND PHARMA


PS Ratio Performance Analysis for GLAND PHARMA

- GLAND PHARMA 's latest p/e ratio is 5.84x.

- GLAND PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.94x.

- GLAND PHARMA 's operated at median p/e ratio of 5.76x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GLAND PHARMA 's p/e ratio peaked in Mar2022 at 12.21x.

- GLAND PHARMA 's p/e ratio hit its five-year low in Mar2025 of 4.67x.


How does GLAND PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
GLAND PHARMA 6,430.75.8437,541.6
SUN PHARMACEUTICAL INDUSTRIES LTD58,462.07.35429,469.0
DIVIS LABORATORIES LTD10,560.016.41173,305.0
TORRENT PHARMACEUTICALS LTD13,980.010.44146,014.0
CIPLA LTD28,162.63.96111,388.0
DR REDDYS LABORATORIES LTD33,700.23.16106,381.0
MANKIND PHARMA LTD14,277.66.6594,907.2
LUPIN LTD27,958.03.68102,853.0
ZYDUS LIFESCIENCES LTD27,148.43.99108,397.0
AUROBINDO PHARMA LTD33,653.12.4482,241.6
LAURUS LABS LTD6,812.910.9674,673.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GLAND PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.44x
Max industry PS 16.41x
Median industry PS 5.84x
Average industry PS 6.81x



You may also like the below Video Courses